H.R. 2337 · 114th Congress
To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.
- Stage
- In committee
- Sponsor
- Joseph Pitts
- Introduced
- 2015-05-14
- Latest action
- 2015-05-15 · Referred to the Subcommittee on Health.
Subjects
Health
Health technology, devices, supplies
Drug safety, medical device, and laboratory regulation
Manufacturing